Drug Target Review2024-09-25T12:06:34
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-11-06T07:26:00Z
Author Dr Tina Rogers
2026-11-03T12:09:00Z
2026-08-11T07:02:00
Contributor Professor Joseph C. Wu, Drug Target Review
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2026-08-24T08:43:00
Author Dr Dana Watt
2023-04-04T15:03:09
Sponsored by Agilent
Site powered by Webvision Cloud